|
Re: Another reason
|
6
|
Resverlogix Corp.
|
Jan 10, 2022 05:19PM
|
|
Re: Another Report of Exempt Distribution
|
2
|
Resverlogix Corp.
|
Mar 19, 2023 08:35PM
|
|
Re: Another RVX-208 Poster at IAS 2015 May 26
|
4
|
Resverlogix Corp.
|
May 19, 2015 02:49PM
|
|
Re: Another Week
|
4
|
Resverlogix Corp.
|
Oct 21, 2022 07:05PM
|
|
Re: Anybody ever post this link already?
|
6
|
Resverlogix Corp.
|
Apr 14, 2023 11:00AM
|
|
Re: Anyone ......
|
3
|
Resverlogix Corp.
|
Oct 10, 2015 09:40AM
|
|
Re: Anyone else find it odd......
|
4
|
Resverlogix Corp.
|
Aug 19, 2019 04:56PM
|
|
Re: Anyone read Chinese?
|
1
|
Resverlogix Corp.
|
Oct 26, 2017 03:01PM
|
|
Re: Apabetalone Inhibits SARS-CoV-2 Infection at Levels Comparable to Approved Antiviral
|
4
|
Resverlogix Corp.
|
Mar 15, 2021 11:02AM
|
|
Re: Apabetalone MOA diagram
|
2
|
Resverlogix Corp.
|
Sep 28, 2019 02:57PM
|
|
Re: Apabetalone MOA diagram
|
7
|
Resverlogix Corp.
|
Sep 29, 2019 12:30PM
|
|
Re: Apabetalone treatment reduces SARS-CoV-2 infectivity and completely prevents cardiac damage in a cytokine-storm model
|
8
|
Resverlogix Corp.
|
Mar 03, 2021 10:31AM
|
|
Re: Apabetalone’s Positive Impact on COVID-19 in Human Lung Cells Published in Biomedicines
|
4
|
Resverlogix Corp.
|
Apr 21, 2021 11:25AM
|
|
Re: Apropos AGM
|
4
|
Resverlogix Corp.
|
Jun 08, 2022 06:27PM
|
|
Re: Apropos AGM
|
6
|
Resverlogix Corp.
|
Jun 08, 2022 01:14PM
|
|
Re: Apropos AGM
|
6
|
Resverlogix Corp.
|
Jun 06, 2022 12:54PM
|
|
Re: Apropos AGM
|
4
|
Resverlogix Corp.
|
Jun 08, 2022 06:22PM
|
|
Re: Array and Zenith
|
4
|
Zenith Epigenetics
|
Jun 22, 2019 12:26PM
|
|
Re: Article
|
7
|
Resverlogix Corp.
|
May 31, 2022 12:54PM
|
|
Re: Article
|
1
|
Resverlogix Corp.
|
Mar 15, 2022 11:27AM
|
